Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival

DNA Repair

Volumn 3, Issue 7, 2004, Pages 729-742

  Drotschmann, Karin ^a   Topping, Ryan P ^a   Clodfelter, Jill E ^a   Salsbury, Freddie R ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

Cell death; Cell survival; MutS homologs

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CISPLATIN; PROTEIN MSH2; PROTEIN MSH6; PROTEIN MUTS; PROTEIN SUBUNIT;

ARTICLE; CELL DEATH; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; GENE MUTATION; MISMATCH REPAIR; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; YEAST;

ADENOSINE TRIPHOSPHATASES; BASE PAIR MISMATCH; CISPLATIN; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA, FUNGAL; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNGAL PROTEINS; HYDROLYSIS; MODELS, MOLECULAR; NUCLEIC ACID HETERODUPLEXES; NUCLEOTIDES; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

BACTERIA (MICROORGANISMS);

EID: 2642554558     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.02.011     Document Type: Article

References (67)

1. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ. 8:2001;1076-1092
2. Jacob S., Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie. 84:2002;27-47
3. Lage H., Dietel M. Involvement of the DNA MMR system in antineoplastic drug resistance. J. Cancer Res. Clin. Oncol. 125:1999;156-165
4. Irving J.A., Hall A.G. Mismatch repair defects as a cause of resistance to cytotoxic drugs. Expert. Rev. Anticancer Ther. 1:2001;149-158
5. Bignami M., Casorelli I., Karran P. Mismatch repair and response to DNA-damaging antitumour therapies. Eur. J. Cancer. 39:2003;2142-2149
6. Kaina B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem. Pharmacol. 66:2003;1547-1554
7. Wozniak K., Blasiak J. Recognition and repair of DNA-cisplatin adducts. Acta Biochim. Polym. 49:2002;583-596
8. Jordan P., Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol. Life Sci. 57:2000;1229-1235
9. Vernole P., Pepponi R., D'Atri S. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother. Pharmacol. 52:2003;185-192
10. Karran P. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis. 22:2001;1931-1937
11. Berardini M., Mazurek A., Fishel R. The effect of O6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3. J. Biol. Chem. 275:2000;27851-27857
12. Shimodaira H., Yoshioka-Yamashita A., Kolodner R.D., Wang J.Y.J. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. U.S.A. 100:2003;2420-2425
13. Li G.-M. The role of MMR in DNA damage-induced apoptosis. Oncol. Res. 11:1999;393-400
14. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehme A., Christen R.D., Howell S.B. The role of DNA MMR in platinum drug resistance. Cancer Res. 56:1996;4881-4886
15. Vaisman A., Varchenko M., Umar A., Kunkel T.A., Risinger J.I., Barrett J.C., Hamilton T.C., Chaney S.G. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58:1998;3579-3585
16. Lin X., Kim H.-K., Howell S.B. The role of DNA mismatch repair in cisplatin mutagenicity. J. Inorg. Biochem. 77:1999;89-93
17. Fink D., Zheng H., Nebel S., Norris P.S., Aebi S., Lin T.P., Nehme A., Christen R.D., Haas M., MacLeod C.L., Howell S.B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57:1997;1841-1845
18. Fourrier L., Brooks P., Malinge J.-M. Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein. J. Biol. Chem. 278:2003;21267-21275
19. Acharya S., Wilson T., Gradia S., Kane M.F., Guerrette S., Marsischky G.T., Kolodner R.D., Fishel R. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13629-13634
20. Duckett D.R., Drummond J.T., Murchie A.I., Reardon J.T., Sancar A., Lilley D.M., Modrich P. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6443-6447
21. Yamada M., O'Regan E., Brown R., Karran P. Selective recognition of a cisplatin-DNA adduct by human MMR proteins. Nucl. Acids Res. 25:1997;491-496
22. Mu D., Tursun M., Duckett D.R., Drummond J.T., Modrich P., Sancar A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human MMR and excision repair systems. Mol. Cell. Biol. 17:1997;760-769
23. Mello J.A., Acharya S., Fishel R., Essigmann J.M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:1996;579-589
24. Zamble D.B., Mu D., Reardon J.T., Sancar A., Lippard S.J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry. 35:1996;10004-10013
25. Moggs J.G., Szymkowski D.E., Yamada M., Karran P., Wood R.D. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucl. Acids Res. 25:1997;480-491
26. Nehme A., Baskaran R., Aebi S., Fink D., Nebel S., Cenni B., Wang J.Y., Howell S.B., Christen R.D. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 57:1997;3253-3257
27. Gong J., Costanzo A., Yang H.-Q., Melino G., Kaelin W.G. Jr., Levrero M., Wang J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809
28. Drotschmann K., Clark A.B., Tran H.T., Resnick M.A., Gordenin D.A., Kunkel T.A. Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2970-2975
29. Tran H.T., Keen J.T., Kricker M., Resnick M.A., Gordenin D.A. Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase proofreading yeast mutants. Mol. Cell. Biol. 17:1997;2859-2865
30. Drotschmann K., Clark A.B., Kunkel T.A. Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr. Biol. 9:1999;907-910
31. Drotschmann K., Yang W., Kunkel T.A. Evidence for sequential action of two ATPase active sites in yeast Msh2-Msh6. DNA Repair. 1:2002;743-753
32. Berman H.M., Westbrook J., Weng Z., Gillard G., Bhat T.N., Weissig H., Shindyalym I.N., Bourne P.E. The Protein Data Bank. Nucl. Acids Res. 29:2000;235-242
33. Drotschmann K., Yang W., Brownewell F.E., Kool E.T., Kunkel T.A. Asymmetric recognition of DNA local distortion: structure-based functional studies of eukaryotic Msh2-Msh6. J. Biol. Chem. 276:2001;46225-46339
34. Humphrey W., Dalke A., Schulten K. VMD - Visual molecular dynamics. J. Mol. Graph. 14:1996;33-38
35. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: a program for macromolecular energy, minimization, and dynamics and calculations. J. Comput. Chem. 4:1983;187-217
36. Wriggers W., Milligan R.A., McCammon J.A. Situs: a package for docking crystal structures into low-resolution maps from electron microscopy. J. Struct. Biol. 125:1998;185-195
37. Junop M.S., Obmolova G., Rausch K., Hsieh P., Yang W. Composite active site of an ABC ATPase: MutS uses ATP to verify mismatch recognition and authorize DNA repair. Mol. Cell. 7:2001;1-12
38. Lamers M.H., Winterwerp H.H.K., Sixma T.K. The alternating ATPase domains of MutS control DNA mismatch repair. EMBO J. 22:2003;746-756
39. Alani E., Sokolsky T., Studamire B., Miret J.J., Lahue R.S. Genetic and biochemical analysis of Msh2p-Msh6p: role of ATP hydrolysis and Msh2p-Msh6p subunit interactions in mismatch base pair recognition. Mol. Cell. Biol. 17:1997;2436-2447
40. Studamire B., Quach T., Alani E. Saccharomyces cerevisiae Msh2p and Msh6p ATPase activities are both required during mismatch repair. Mol. Cell. Biol. 18:1998;7590-7601
41. Lamers M.H., Perrakis A., Enzlin J.H., Winterwerp H.H.K., de Wind N., Sixma T.K. The crystal structure of DNA MMR protein MutS binding to a GT mismatch. Nature. 407:2000;711-717
42. Obmolova G., Bam C., Hsieh P., Yang W. Crystal structures of MMR protein MutS and its complex with a substrate DNA. Nature. 407:2000;703-710
43. Spampinato C., Modrich P. The MutL ATPase is required for mismatch repair. J. Biol. Chem. 275:2000;9863-9869
44. Bowers J., Tran P.T., Joshi A., Liskay R.M., Alani E. MSH-MLH complexes formed at a DNA mismatch are disrupted by the PCNA sliding clamp. J. Mol. Biol. 306:2001;957-968
45. Wang H., Yang Y., Schofield M.J., Du C., Fridman Y., Lee S.D., Larson E.D., Drummond J.T., Alani E., Hsieh P., Erie D.A. DNA bending and unbending by MutS govern mismatch recognition and specificity. Proc. Natl. Acad. Sci. U.S.A. 100:2003;14822-14827
46. Pepponi R., Graziani G., Falcinelli S., Vernole P., Levati L., Lacal P.M., Pagani E., Bonmassar E., Jiricny J., D'Atri S. hMSH3 overexpression and cellular response to cytotoxic anticancer agents. Carcinogenesis. 22:2001;1131-1137
47. Hinz J.M., Meuth M. MSH3 deficiency is not sufficient for a mutator phenotype in Chinese hamster ovary cells. Carcinogenesis. 20:1999;215-220
48. Huang J., Kuismanen S.A., Liu T., Chadwick R.B., Johnson C.K., Stevens M.W., Richards S.K., Meek J.E., Gao X., Wright F.A., Mecklin J.P., Jarvinen H.J., Gronberg H., Bisgaard M.L., Lindblom A., Peltomaki P. MSH6 and MSH3 are rarely involved in genetic predisposition to non-polypotic colon cancer. Cancer Res. 61:2001;1619-1623
49. Akiyama Y., Tsubouchi N., Yuasa Y. Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary non-polyposis colorectal cancers. Biochem. Biophys. Res. Commun. 236:1997;248-252
50. Yin J., Kong D., Wang S., Zou T.T., Souza R.F., Smolinski K.N., Lynch P.M., Hamilton S.R., Sugimura H., Powell S.M., Young J., Abraham J.M., Meltzer S.J. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum. Mutat. 10:1997;474-478
51. Calin G.A., Gafa R., Tibiletti M.G., Herlea V., Becheanu G., Cavazzini L., Barbanti-Brodano G., Nenci I., Negrini M., Lanza G. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: a study of the TGFbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int. J. Cancer. 89:2000;230-235
52. Ohmiya N., Matsumoto S., Yamamoto H., Baranovskaya S., Malkhosyan S.R., Perucho M. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene. 272:2001;301-313
53. Zhang H., Richards B., Wilson T., Lloyd M., Cranston A., Thorburn A., Fishel R., Meuth M. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res. 59:1999;3021-3027
54. Lau P.J., Kolodner R.D. Transfer of the MSH2-MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA. J. Biol. Chem. 278:2003;14-17
55. Heinen C.D., Wilson T., Mazurek A., Berardini M., Butz C. HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell. 1:2002;469-478
56. Gradia S., Subramanian D., Wilson T., Acharya S., Makhov A., Griffith J., Fishel R. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA. Mol. Cell. 3:1999;255-261
57. Iaccarino I., Marra G., Dufner P., Jiricny J. Mutation in the magnesium binding site of hMSH6 disables the hMutS-alpha sliding clamp from translocating along DNA. J. Biol. Chem. 275:2000;2080-2086
58. Baitinger C., Burdett V., Modrich P. Hydrolytically deficient MutS E694A is defective in the MutL-dependent activation of MutH and in the mismatch-dependent assembly of the MutS-MutL-heteroduplex complex. J. Biol. Chem. 278:2003;49505-49511
59. Selmane T., Schofield M.J., Nayak S., Du C., Hsieh P. Formation of a DNA mismatch repair complex mediated by ATP. J. Mol. Biol. 334:2003;949-965
60. Lin D.P., Wang Y., Scherer S.J., Clark A.B., Yang K., Avdievich E., Jin B., Werling U., Parris T., Kurihara N., Umar A., Kucherlapati R., Lipkin M., Kunkel T.A., Edelmann W. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res. 64:2004;517-522
61. Haber L.T., Walker G.C. Altering the conserved nucleotide binding motif in the Salmonella typhimurium MutS mismatch repair protein affects both its ATPase and mismatch binding activities. EMBO J. 10:1991;2707-2715
62. Blackwell L.J., Martik D., Bjornson K.P., Bjornson E.S., Modrich P. Nucleotide-promoted release of hMutS alpha from heteroduplex DNA is consistent with an ATP-dependent translocation mechanism. J. Biol. Chem. 273:1998;32055-32062
63. Acharya S., Foster P.L., Brooks P., Fishel R. The coordinated functions of the E. coli MutS and MutL proteins in mismatch repair. Mol. Cell. 12:2003;233-246
64. Marsischky G.T., Filosi N., Kane M.F., Kolodner R. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dev. 10:1996;407-420
65. Palombo F., Iaccarino I., Nakajima E., Ikejima M., Shimada T., Jiricny J. hMutS-beta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 6:1996;1181-1184
66. Sia E.A., Kokoska R.J., Dominska M., Greenwell P., Petes T.D. Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes. Mol. Cell Biol. 17:1997;2851-2858
67. Alani E., Lee J.Y., Schofield M.J., Kijas A.W., Hsieh P., Yang W. Crystal structure and biochemical analysis of the MutS-ADP-beryllium fluoride complex suggests a conserved mechanism for ATP interactions in mismatch repair. J. Biol. Chem. 278:2003;16088-16094